CAPTRUST Financial Advisors’s Genomic Health, Inc. GHDX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200	Closed	-$14K	–	2039
2019 Q3	$14K	Hold	200	–	–	﹤0.01%	1408
2019 Q2	$12K	Buy	+200	New	+$11.8K	﹤0.01%	1459

CAPTRUST Financial Advisors's GHDX Position: Q4 2019 in Review

CAPTRUST Financial Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 200 shares — an estimated $14K sold.

CAPTRUST Financial Advisors first reported a position in GHDX in Q2 2019 and held it in 2 quarters. The position peaked at $14K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

CAPTRUST Financial Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
CAPTRUST Financial Advisors sold 200 Genomic Health, Inc. shares in Q4 2019, an estimated $14K.
CAPTRUST Financial Advisors first reported a position in Genomic Health, Inc. in Q2 2019 and held it in 2 quarters.
CAPTRUST Financial Advisors's Genomic Health, Inc. position peaked at $14K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.